1. Passouant O, Mateu P, Commandini M, Brenkle K, Just B. Pulmonary aspergillosis in non-immunocompromised patient with acute respiratory distress syndrome during A (H1N1) infection. Ann Fr Anesth Reanim. 2011. 30:e75–e76.
Article
2. Stevens DA, Melikian GL. Aspergillosis in the 'nonimmunocompromised' host. Immunol Invest. 2011. 40:751–766.
Article
3. Garcia-Vidal C, Barba P, Arnan M, Moreno A, Ruiz-Camps I, Gudiol C, Ayats J, Ortí G, Carratalà J. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis. 2011. 53:e16–e19.
Article
4. Carfagna P, Brandimarte F, Caccese R, Campagna D, Brandimarte C, Venditti M. Occurrence of influenza A(H1N1)v infection and concomitant invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Mycoses. 2011. 54:549–551.
Article
5. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011. 20:156–174.
Article
6. Dutkiewicz R, Hage CA. Aspergillus infections in the critically ill. Proc Am Thorac Soc. 2010. 7:204–209.
7. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, León C, Alvarez-Lerma F, Nolla-Salas J, Iruretagoyena JR, Barcenilla F. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care. 2005. 9:R191–R199.
8. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004. 170:621–625.
Article
9. Kwoun MO, Ling PR, Lydon E, Imrich A, Qu Z, Palombo J, Bistrian BR. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr. 1997. 21:91–95.
Article
10. Janes SM, Barker KF, Mak V, Bell D. Invasive pulmonary aspergillosis in an insulin-dependent diabetic. Respir Med. 1998. 92:972–975.
Article
11. Grizzanti JN, Knapp A. Diabetic ketoacidosis and invasive aspergillosis. Lung. 1981. 159:43–49.
Article
12. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock. 1999. 11:153–159.
Article
13. Guarner J, Falcón-Escobedo R. Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res. 2009. 40:655–661.
Article
14. Lewis DE, Gilbert BE, Knight V. Influenza virus infection induces functional alterations in peripheral blood lymphocytes. J Immunol. 1986. 137:3777–3781.
15. Astry CL, Jakab GJ. Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis. J Virol. 1984. 50:287–292.
Article
16. Lee FE, Daigle CC, Urban MA, Metlay LA, Treanor JJ, Trawick DR. Fever and progressive respiratory failure in three elderly family members. Chest. 2005. 128:1863–1864. 1865–1867.
Article
17. Adalja AA, Sappington PL, Harris SP, Rimmele T, Kreit JW, Kellum JA, Boujoukos AJ. Isolation of Aspergillus in three 2009 H1N1 influenza patients. Influenza Other Respi Viruses. 2011. 5:225–229.
18. Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis. 2010. 16:971–973.
Article
19. Kim SH, Kim MN, Lee SO, Choi SH, Kim YS, Woo JH, Lim CM, Koh Y, Hong SB. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis. Mycoses. 2012. 55:189–192.
Article
20. Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG, Stevens DA, Graybill JR. I3
Aspergillus Study Group. Invasive aspergillosis. Disease spectrum, treatment practices,
and outcomes. Medicine (Baltimore). 2000. 79:250–260.
Article
21. Britt RH, Enzmann DR. Clinical stages of human brain abscesses on serial CT scans after contrast infusion. Computerized tomographic, neuropathological, and clinical correlations. J Neurosurg. 1983. 59:972–989.
Article